International Journal of Pharma and Bio Sciences
 
 
    ISSN 0975-6299
www.ijpbs.net


ORIGINAL RESEARCH ARTICLE
Int J Pharm Bio Sci Volume 13 issue 2, April - June, Pages:1-8

Simple and Rapid Method Development for Glycopyrrolate Injection Using High-Performance Liquid Chromatography (HPLC)

M. Prasada Reddy, O. Sreekanth Reddy, K. Chowdoji Rao and M.C.S. Subha
DOI: http://dx.doi.org/10.22376/ijpbs.2022.13.2.P1-8
Abstract:

The main aim of the present work is to develop a simple and rapid method for determining the impurity profile of related substances in glycopyrrolate from glycopyrrolate injection using high-performance liquid chromatography (HPLC). This method makes use of the C8 (Kromasil 100 250 mm x 4.6mm, 5μ) particle size column for rapid separation of related substances of glycopyrrolate from glycopyrrolate injection along with the related substances using ultraviolet and photodiode array detectors (UV/PDA), pH2.9±0.05 potassium dihydrogen phosphate buffer solution with the column temperature was 45°C, the gradient elution mode, and the wavelength of detection was 222 nm. The procedure was tested in order to prove its efficacy for the intended use. In the case of glycopyrrolate, peak responses were shown to be linear throughout impurity values of 0.05 to 0.75 ppm. For glycopyrrolate, the correlation coefficient was found to be 0.999. This method will be beneficial for determining the impurity profile of glycopyrrolate-related compounds in the injection dosage form of glycopyrrolate. The sample and standard solutions are found to be stable at refrigerator temperature for up to 48 h, while the standard solution is found to be stable on the bench-top for up to 48 h. The results for specificity (degradation), precision, accuracy, LOD, LOQ, and robustness were determined to be satisfactory. The method is simple, rapid, and selective; the described method is precise for estimation of related substances in glycopyrrolate injection. Our results demonstrated that the developed method warrants further development for use in the pharmaceutical industry, such as regular quality control analysis.

Keywords: Glycopyrrolate, HPLC, Related substances, LOD, LOQ, Buffer solution.
Full HTML:

Refeences

  1. The United States pharmacopeial convention. U.S. Pharmacopeia national formulary 2017: USP 40. NF. 2016;1:35.
  2. Garnock-Jones KP. Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions. Paediatr Drugs. 2012;14(4):263-9. doi: 10.2165/11208120-000000000-00000, PMID 22646067.
  3. Storme ML, t’Kindt RS, Goeteyn W, Reyntjens K, Van Bocxlaer JF. Quantitative determination of glycopyrrolate in human plasma by liquid chromatography-electrospray ionization mass spectrometry: the use of a volatile ion-pairing agent during both liquid-liquid extraction and liquid chromatography. J Chromatogr B AnalytTechnol Biomed Life Sci. 2008 Dec 1;876(1):24-30. doi: 10.1016/j.jchromb.2008.10.013, PMID 18977186.
  4. Ben Abraham RB, Rudick V, Weinbroum AA, Department of Anesthesiology and Critical Care Medicine, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine. Practical guidelines for acute care of victims of bioterrorism: conventional injuries and concomitant nerve agent intoxication. Anesthesiology. 2002 Oct 1;97(4):989-1004. doi: 10.1097/00000542-200210000-00035, PMID 12357169.
  5. Chabicovsky M, Winkler S, Soeberdt M, Kilic A, Masur C, Abels C. Pharmacology, toxicology and clinical safety of glycopyrrolate. ToxicolApplPharmacol. 2019;370:154-69. doi: 10.1016/j.taap.2019.03.016, PMID 30905688.
  6. Walker JR. Neuromuscular relaxation and reversal: an update. J PerianesthNurs. 1997;12(4):264-74. doi: 10.1016/s1089-9472(97)80007-x, PMID 9287638.
  7. Uberoi R, editor. Interventional radiology. Oxford specialist handbooks. 2009.
  8. Chabicovsky M, Winkler S, Soeberdt M, Kilic A, Masur C, Abels C. Pharmacology, toxicology and clinical safety of glycopyrrolate. ToxicolApplPharmacol. 2019;370:154-69. doi: 10.1016/j.taap.2019.03.016, PMID 30905688.
  9. Mirakhur RK, Dundee JW. Glycopyrrolate: pharmacology and clinical use. Anaesthesia. 1983;38(12):1195-204. doi: 10.1111/j.1365-2044.1983.tb12525.x, PMID 6660460.
  10. Jääskeläinen IP, Hirvonen J, Huttunen J, Kaakkola S, Pekkonen E. Scopolamine enhances middle-latency auditory evoked magnetic fields. NeurosciLett. 1999 Jan 4;259(1):41-4. doi: 10.1016/s0304-3940(98)00893-3, PMID 10027551.
  11. Gupta S, Bansal G. Validated stability-indicating HPLC-UV method for simultaneous determination of glipizide and four impurities. J AOAC Int. 2011;94(2):523-30. doi: 10.1093/jaoac/94.2.523, PMID 21563686.
  12. El-Zaher AA, Elkady EF, Elwy HM, Saleh MA. Simultaneous determination of metformin, glipizide, repaglinide, and glimepiride or metformin and pioglitazone by a validated LC method: application in the presence of metformin impurity (1-cyanoguanidine). J AOAC Int. 2016 Jul 1;99(4):957-63. doi: 10.5740/jaoacint.15-0291, PMID 27214744.
  13. Adhikari L, Jagadev S, Sahoo S, Murthy PN, Mishra US. Development and Validation of UV-Visible spectrophotometric Method for Simultaneous Determination of pioglitazone hydrochloride, metformin hydrochloride and glipizide in its Bulk and Pharmaceutical Dosage Form (Tablet). Int J ChemTech Res. 2012;4(2):625-30.
  14. Xavier CM, Basavaiah K, Vinay KB, Swamy N. Quality by design approach for the development and validation of glipizide, an antidiabetic drug, by RP-UPLC with application to formulated forms and urine. ISRN Chromatogr. 2013;2013:1-10. doi: 10.1155/2013/738397, PMID 738397.
  15. Goyal S, Gupta A, Bhatt N, Rani R. Development and validation of RP-HPLC method for estimation of glipizide in bulk drug and pharmaceutical formulation. Int J PharmTech Res. 2013;5(1):183-8.
  16. Lakshmi KS, Rajesh T. Development and validation of RP-HPLC method for simultaneous determination of glipizide, rosiglitazone, pioglitazone, glibenclamide and glimepiride in pharmaceutical dosage forms and human plasma. J Iran Chem Soc. 2011;8(1):31-7. doi: 10.1007/BF03246199.
  17. Triveni D, Kumar GVS, Puranik SB, Kumar NS, Sridhar KA. Development and Validation of RP- HPLC method for Simultaneous estimation of glipizide and metformin in bulk drugs and tablet dosage form. Int Res J Pharm. 2012;3(9):260.
  18. Prasada Reddy M, Subha MCS. An HPLC method for qualitative and quantitative determination of fosaprepitant in Pharmaceutical products. Int J Pharm Biol Sci. 2018;9:125-41.
  19. Rumpler MJ, Sams RA, Colahan P. Regulatory control of glycopyrrolate in performance horses using validated UHPLC/MS–MS methods. J Chromatogr B AnalytTechnol Biomed Life Sci. 2012 Mar 15;889-890:130-7. doi: 10.1016/j.jchromb.2012.02.008, PMID 22377405.
  20. Gandala K, Pabba P. Akula G. RPHPLC method development and validation for estimation of glycopyrrolate in bulk and tablet dosage forms Asian J Pharm Clin Res. 2011;4(4):37-40.
  21. Erukulla KK, Rengitham SS. Synchronous estimation of glycopyrrolate and formoterol in bulk and pharmaceutical dosage form by RP-HPLC method. Indian J Pharm Educ Res. 2018;52(4):S47-55.
  22. Kusuma J, Mandava VBR, Rudraraju R. Development and validation of Stability indicating RP-HPLC method for the estimation of glycopyrrolate and neostigmine in bulk and tablet dosage form. Int J Scieng Res. 2016;7(12):1236-42.
  23. Dwivedi J, Patel D, Khushboo Patel DM. Development and validation of first-order derivative spectrophotometry for simultaneous determination of indacaterol maleate and glycopyrronium bromide in pharmaceutical dosage form. Int J Res Pharm Biosci. 2017;4(3):12-8.
  24. Dwivedijaya Pd. Patel khushboo, MeshramDhananjay. Development and validation of chromatographic and spectrophotometric methods for simultaneous estimation of indacaterol maleate and glycopyrronium bromide in pharmaceutical dosage form and their comparison using Student t-test. J Glob Trends Pharm Sci. 2017;8(3):4204-16.
  25. Ashwini B, Shymala M, Sharma JVC. Analytical method validation report for essay of Glycopyrrocate and FormoteralFumerate by RP-HPLC. Int J ChemPharmSci. 2018;6(1):01-8.
  26. Kalaiselvan A, Xavier Rajarathinam SR, Chandran S. Simultaneous quantification of formoterolfumarate and glycopyrrolate using reverse phase high performance liquid chromatography. Asian J Chem. 2018;30(11):2389-93. doi: 10.14233/ajchem.2018.21370.
  27. Patel K, Patel D, Dwivedi J, Newal P, DhananjayMeshram A. Review on analytical techniques for estimation of anti cholinergic drug: glycopyrronium bromide. Asian J Pharm Ana. 2017;7(4):239-42.
  28. Mishra S, Arora V. Analytical method validation of HPLC method for assay of anticholinergic drug in parenteral formulation. Int J Pharm Res Scholars. 2016;5(4):101-4.
  29. Kapupara PP, Ajudia RP. Ketan Shah. UV spectrophotometric method for simultaneous estimation of glycopyrrolate and formoterolfumarate in their synthetic mixture by absorbance correction method. J Chem Pharm Res. 2018;10(5):30-40.
  30. ICH harmonised tripartite guideline, validation of analytical procedures: text and methodology;Q2:(R1), Parent Guideline dated 27 October 1994.
  31. Tijssen R. The Mechanisms and Importance of Zone-Spreading, u E. Katz, R. Eksteen, P. Schoenmakers, N. Miller (Ed.): Handbook of HPLC, Vol. 78, Marcel Dekker, New York-Basel, 1998.
  32. Snyder LR, Kirkland JJ, Glajch JL. Practical HPLC method development, John Wiley & Sons, 2012
  33. Ahuja S, Dong M. Handbook of pharmaceutical analysis by HPLC, Elsevier, 2005
  34. Wang L, Zheng J, Gong X, Hartman R, Antonucci V. J Pharm Biomed Anal. 2015;104:49-5.
  35. Lakka NS, Kuppan C. Principles of chromatography method development, Vol. 10, IntechOpen, 2019.
  36. Ettre LS, Horvath C. Foundations of modern liquid chromatography. Anal Chem. 1975, 47, 422A-446a.
  37. Joshi VS, Kumar V, Rathore AS. Role of organic modifier and gradient shape in RP-HPLC separation: analysis of GCSF variants. J chromatogr sci. 2015, 53, 417-423.
  38. Neue UD. HPLC columns; Theory, Technology, and Practice, Wiley-VCH, 1997.
  39. Meyer VR. Practical high-performance liquid chromatography, John Wiley & Sons, 2013.
  40. .Swartz M. Journal of Liquid Chromatography & Related Technologies 2010, 33, 1130-1150.
  41. <1225>USP 43 and NF 38, General chapter, Verification of compendial procedures, page 8166. Retrieved Jan 21, 2021 from: https://www.dcvmn.org/IMG/pdf/usp_1226_verification_of_methods.pdf
  42. <1226> USP 43 and NF 38, General chapter, Verification of compendial procedures, page 8166. Retrieved Jan 21, 2021 from: https://www.dcvmn.org/IMG/pdf/usp_1226_verification_of_methods.pdf
  43. FDA Guidance Document on, Analytical Procedures and Methods Validation for Drugs and Biologics, July 2015. Retrieved Feb 1, 2021 from: https://www.fda.gov/media/87801/download
  44. Harvey D. Modern analytical chemistry, Vol. 1, McGraw-Hill New York, 2000.
  45. ICH Q14: Analytical Procedure Development and Revision of Q2(R1) Analytical Validation dated 14 November 2018 Endorsed by the Management Committee on 15 November 2018. Retrieved Feb 8, 2021 from: https://database.ich.org/sites/default/files/Q2R2-Q14_EWG_Concept_Paper.pdf.
[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech Solutions
         Home I Contact I Terms & Conditions